Skip to content

A pilot trial of a tailored mindfulness-based group intervention for psychological distress and adjustment in an oncology population

Feasibility study of a tailored mindfulness-based group intervention for psychological distress and adjustment for allogeneic hematopoietic stem cell transplant outpatients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN61068398
Enrollment
35
Registered
2024-10-03
Start date
2016-01-01
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tailored mindfulness-based group intervention for psychological distress and adjustment for allogeneic hematopoietic stem cell transplant outpatients Mental and Behavioural Disorders

Interventions

The intervention included elements of both Mindfulness Based Stress Reduction and Mindfulness Based Cognitive Therapy. Each mindfulness group consisted of six 1.5-hour face-to-face weekly group sessio

Sponsors

University of Melbourne
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. 18 years of age and over 2. A diagnosis of haematologic cancer 3. Had undergone Hematopoietic stem cell transplant (HSCT) at least 30 days before enrolment in the study

Exclusion criteria

Exclusion criteria: 1. If they had comorbid medical issues 2. Significant cognitive impairment that interfered with their ability to attend the program 3. Were participating in other psychological treatments during the trial 4. Had a history of severe mental illness (e.g., schizophrenia or bipolar disorder) 5. Did not read, write, or understand English

Design outcomes

Primary

MeasureTime frame
Measured at T1: baseline; T2: 6 weeks post intervention; T3: 3 months post intervention: 1. Level of depression measured using the Beck Depression Inventory (BDI-II) 2. Level of anxiety measured using the State-Trait Anxiety Inventory (STAI) 3. Quality of life measured using the Functional Assessment of Cancer Therapy – Bone Marrow Transplant (FACT-BMT) 4. Level of psychological adjustment measured using the Mini-Mental Adjustment to Cancer Scale (Mini-MAC)

Secondary

MeasureTime frame
Measured at T1: baseline; T2: 6 weeks post intervention; T3: 3 months post intervention: 1. Mindfulness skills were assessed using the Five Facet Mindfulness Questionnaire (FFMQ) 2. Emotion regulation skills were measured with the Emotion Regulation Questionnaire (ERQ) 3. Decentring was measured with the Experiences Questionnaire (EQ) 4. Health domains affected by cancer measured using the Patient-Reported Outcome Measurement Information System (PROMIS) Cancer Scales, including fatigue, pain interference, physical functioning, and emotional distress 5. The tailored group mindfulness program's acceptability and feasibility measured using data collected during a treatment evaluation questionnaire and an optional 30-minute qualitative interview

Countries

Australia

Contacts

Public ContactLitza Kiropoulos
litzak@unimelb.edu.au+61 3 9035 4063

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026